Long-acting Exparel helps reduce post-surgery pain, data show

09/2/2013 | Modern Medicine

Plastic surgery patients who took extended-release bupivacaine liposome injectable suspension, such as Exparel and Pacira, as an adjunct treatment to help control pain reported lower pain scores and used fewer opioid drugs, according to a study presented at the American Society for Aesthetic Plastic Surgery meeting. Plastic surgeon Stephan Finical of Charlotte Plastic Surgery, who wrote about the study in Cosmetic Surgery Times, said the drug worked well for patients having breast augmentation or reduction surgery or abdominoplasty, so he is "extending its use to facial cosmetic surgery."

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC